Menu

Frogs Fight Back From Fungal Attack

A decade after chytridiomycosis killed scores of amphibians in Panama, some species are recovering. New research indicates why.  

Mar 29, 2018
Ruth Williams

Speckled glass frog in PanamaDOUGLAS WOODHAMSIn Panama, between 2004 and 2007, an outbreak of the amphibian disease chytridiomycosis resulted in countless salamander and frog fatalities. But certain species have since recovered, despite the continued presence of the pathogenic fungus responsible for the die-off. An investigation into both the pathogen and its hosts, reported in Science today (March 29), reveals that while the fungus remains as virulent as ever, the surviving host species are less susceptible.

“I see this as a fundamental discovery, and one that is positive and I am very optimistic about,” says Peter Daszak, president of EcoHealth Alliance in New York, a nonprofit organization dedicated to protecting wildlife and public health from disease. “What the paper says is, there is hope that natural evolutionary processes will lead to some populations bouncing back. It’s very good news.”

The results suggest the hosts may have evolved.—Scott Edwards, Harvard University

The fungus Batrachochytrium dendrobatidis, which causes chytridiomycosis, infects the skin of amphibians, and so perturbs the animals’ osmotic regulation. The resulting imbalance of body fluids leads to organ failure and death. First identified in Australia and Central America in 1998, the disease has wreaked havoc across the globe, decimating species along the way, in part because of the movement of amphibians by humans. “There are multiple global trades in frogs,” such as the pet and food markets, says Daszak, who was not involved with the research. And where the frogs go, the pathogens hitch a ride.

Indeed, the 2004 Panama outbreak was thought to be due to a human-caused introduction of the fungus to host species “that had never seen this pathogen before,” says chytridiomycosis expert Jamie Voyles of the University of Nevada who led the research. From the numbers of dead and dying frogs, she adds, “it was patently clear that [the disease] had a really big impact on those amphibian communities.”

More recently, when Voyles and her team returned to Panama to monitor the sites of the outbreak, they found that some of the amphibian species were recovering, despite samples from the animals revealing the fungus was still present.

“If the frogs were recovering,” says Voyles, the question was, “How were they doing it? Was it because of a change in the pathogen, the frogs, or both?”

See “Do Pathogens Gain Virulence as Hosts Become Resistant?

Voyles had her money on the fungus. With pathogens tending to have shorter life spans than their hosts, she reasoned, “you could imagine how a pathogen might evolve to be less deadly in a short amount of time.”

“One standard expectation is that pathogens become less virulent as they course through a new species,” agrees evolutionary biologist Scott Edwards of Harvard University who did not participate in the research. It stands to reason that if a pathogen kills a host instead of keeping it mildly sick, it will have a poorer chance of spreading.

But when Voyles and colleagues compared contemporary samples of B. dendrobatidis collected from Panamanian amphibians with samples collected at the time of the outbreak they were, by all measures, practically unchanged. The team examined the pathogen’s growth rate, ability to produce infectious zoospores, pathogenicity in live animals, and whole genome sequences, finding no significant differences between the historical and current samples.

“I was very surprised,” says Voyles.

She and her colleagues then turned their attention to the amphibians themselves. Skin secretion samples—which contain antimicrobial peptides—collected from the frogs and salamanders before the disease outbreak and since the recovery exhibited differences in their abilities to block the growth of B. dendrobatidis. Although the pathogen-inhibiting ability of the secretions varied considerably from species to species, in all cases those samples taken from before the disease outbreak were less effective than those taken after. It is not yet clear how the secretions have changed.

“We don’t think this is the only thing the frogs have going for them,” Voyles says of the antimicrobial secretions. It’s likely that the more-resistant amphibian communities also have genetic, behavioral, and other adaptations that help them stave off the pathogens, she says.

“The results suggest the hosts may have evolved,” says Edwards, which is “very exciting and offers a glimmer of hope that some species are able to evolve in response to such a devastating pathogen.”

That said, he adds, “The severity of this [outbreak] should not be diminished.” Voyles team estimates that only approximately 20 percent of the local species that were initially affected by the disease have since recovered. As for the rest, says Voyles, “we do not yet know how many have been lost for good, and how many may still recover.” 

J. Voyles et al., “Shifts in disease dynamics in a tropical amphibian assemblage are not due to pathogen attenuation,” Science, 359:1517-19, 2018.

 

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.